Thursday, February 26, 2009

Sculptra Outcomes for Darker Skin Types?

Upon their approval of the heavy-duty filler Sculptra, the FDA mandated that additional clinical trials be performed upon darker-skinned patients for the treatment of HIV-related facial atrophy. The original trials heavily focused on white males.

The Global Medical News Network is out a writeup of the five year study, conducted by Dr. Douglas Mest of Blue Pacific Aesthetic Group in Manhattan Beach, CA.

The results are good, here at year one. A question was whether darker-skinned patients would create too much collagen, causing hypertrophic scars and keloids. But it turned out that "they do very well with this product," according to Dr. Mest, with new collagen forming more quickly than light-skinned patients without any unwanted side effects.

You can see the results in the picture above. SMAC offers Sculptra to restore volume after lipoatrophy, a.k.a facial fat loss.

Dr. Jason Pozner
Sanctuary Medical Aesthetic Center

Dr. David J. Goldberg
Sanctuary Medical Aesthetic Center
Skin Laser Surgery Specialists of NY/NJ

No comments:

Post a Comment